110 related articles for article (PubMed ID: 30446567)
1. Surveillance of Myelodysplastic Syndrome via Migration Analyses of Blood Neutrophils: A Potential Prognostic Tool.
Schuster M; Moeller M; Bornemann L; Bessen C; Sobczak C; Schmitz S; Witjes L; Kruithoff K; Kohn C; Just O; Kündgen A; Pundt N; Pelzer B; Ampe C; Van Troys M; Nusch A; Haas R; Germing U; Martens L; Jöckel KH; Gunzer M
J Immunol; 2018 Dec; 201(12):3546-3557. PubMed ID: 30446567
[TBL] [Abstract][Full Text] [Related]
2. Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib.
Bornemann L; Schuster M; Schmitz S; Sobczak C; Bessen C; Merz SF; Jöckel KH; Haverkamp T; Gunzer M; Göthert JR
BMC Cancer; 2020 Jul; 20(1):650. PubMed ID: 32660441
[TBL] [Abstract][Full Text] [Related]
3. Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Blanco ML; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu M; Ferrer A; Sanz GF; Florensa L
Am J Hematol; 2017 Jul; 92(7):614-621. PubMed ID: 28370234
[TBL] [Abstract][Full Text] [Related]
4. [Correlations between membrane integrins and granulocyte defects in myelodysplastic syndromes].
Pasotti D; Mazzone A; Fossati G; Mazzucchelli I; Pistone MC; Montagna M; Parachini N; Labbate G; Corti C; Ricevuti G
Recenti Prog Med; 1993 Nov; 84(11):742-9. PubMed ID: 8290785
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and functional characterization of neutrophils and monocytes from patients with myelodysplastic syndrome by flow cytometry.
Schmidt CS; Aranda Lopez P; Dopheide JF; Schmidt F; Theobald M; Schild H; Lauinger-Lörsch E; Nolte F; Radsak MP
Cell Immunol; 2016 Oct; 308():19-26. PubMed ID: 27417453
[TBL] [Abstract][Full Text] [Related]
6. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
Wesa KM; Cunningham-Rundles S; Klimek VM; Vertosick E; Coleton MI; Yeung KS; Lin H; Nimer S; Cassileth BR
Cancer Immunol Immunother; 2015 Feb; 64(2):237-47. PubMed ID: 25351719
[TBL] [Abstract][Full Text] [Related]
7. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Impaired Neutrophil Migration by MicroRNAs in Myelodysplastic Syndromes.
Cao M; Shikama Y; Kimura H; Noji H; Ikeda K; Ono T; Ogawa K; Takeishi Y; Kimura J
J Immunol; 2017 Mar; 198(5):1887-1899. PubMed ID: 28130497
[TBL] [Abstract][Full Text] [Related]
9. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
10. Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
Falantes JF; Calderón C; Márquez Malaver FJ; Alonso D; Martín Noya A; Carrillo E; Martino ML; Montero I; González J; Parody R; Espigado I; Pérez-Simón JA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):144-52. PubMed ID: 23137720
[TBL] [Abstract][Full Text] [Related]
11. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
13. Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.
Voso MT; Fenu S; Latagliata R; Buccisano F; Piciocchi A; Aloe-Spiriti MA; Breccia M; Criscuolo M; Andriani A; Mancini S; Niscola P; Naso V; Nobile C; Piccioni AL; D'Andrea M; D'Addosio A; Leone G; Venditti A
J Clin Oncol; 2013 Jul; 31(21):2671-7. PubMed ID: 23796988
[TBL] [Abstract][Full Text] [Related]
14. Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.
Fuhler GM; Knol GJ; Drayer AL; Vellenga E
J Leukoc Biol; 2005 Feb; 77(2):257-66. PubMed ID: 15561756
[TBL] [Abstract][Full Text] [Related]
15. Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index.
van Spronsen MF; Ossenkoppele GJ; Holman R; van de Loosdrecht AA
Eur J Cancer; 2014 Dec; 50(18):3198-205. PubMed ID: 25454415
[TBL] [Abstract][Full Text] [Related]
16. Abnormal neutrophil scattergram obtained using Pentra MS CRP in the patients with myelodysplastic syndrome showing dysgranulopoiesis.
Inaba T; Ishizuka K; Yuasa S; Mishima N; Ogura K; Saito K; Kohno T; Fujitomo Y; Nakanishi M; Fujita N
Int J Lab Hematol; 2016 Feb; 38(1):27-33. PubMed ID: 26333345
[TBL] [Abstract][Full Text] [Related]
17. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
18. Signalling defect in FMLP-induced neutrophil respiratory burst in myelodysplastic syndromes.
Nakaseko C; Asai T; Wakita H; Oh H; Saito Y
Br J Haematol; 1996 Dec; 95(3):482-8. PubMed ID: 8943888
[TBL] [Abstract][Full Text] [Related]
19. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
[TBL] [Abstract][Full Text] [Related]
20. Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register.
Moreno Berggren D; Folkvaljon Y; Engvall M; Sundberg J; Lambe M; Antunovic P; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ejerblad E
Br J Haematol; 2018 Jun; 181(5):614-627. PubMed ID: 29707769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
